Exchange: NASDAQ·Updated 08:17 PM EDT
RAIL logo

RAIL FreightCar America Inc

$4.70
$0.07
(1.18%)
Today
Closed $5.85
$1.15
(19.66%)
Overnight
EarningsNov 9
Mkt Cap$194.12M
Vol178,180.00

About RAIL

FreightCar America, Inc. engages in the manufacturing of railcars and railcar components. The firm offers freight cars including box cars, covered hoppers, open top hoppers, gondolas, intermodal, and non-intermodal flat cars that transport dry bulk and containerized freight products. It operates through the Manufacturing and Aftermarket segments. The Manufacturing segment includes new railcar manufacturing, used railcar sales, and railcar conversions and rebodies. The Aftermarket segment deals with the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company was founded in 1901 and is headquartered in Chicago, IL.
49

Neutral Sentiment

How do you feel about RAIL?

osubuck30
$RAIL no brainer under $6. They have taken a lot of cost out of business. EBITDA $36-$44 million. Last time they had around the midpoint of their new revenue outlook EBITDA was around $15 million.
1
osubuck30
$RAIL what a disaster with afterhours news…. I mean how can you trust management at this time? Likely heading to mid $3’s
filecrux
$RAIL Follow-up: Railcar maker FreightCar America pulled a 1,285-car tank car retrofit order from backlog, saying the customer is unlikely to meet its contract, and cut 2026 adjusted EBITDA guidance to $15-19M from the $36-44M in its August 3, 2026 Q2 release. Market value: about $192M at $5.86, 16:40 ET Oct 19, 2026; 2026 revenue guidance falls to $370-410M from $410-460M. Other side: CEO says no other orders are affected; backlog left is 2,660 units worth $284.5M at Sept 30. Full Q3 results Nov 9, call Nov 10.
filecrux
$RAIL Railcar maker FreightCar America's pill ended; OC III funds that beneficially own about 48.8% of the common stock, including shares issuable on exercise of warrants (per their July 2, 2026 Schedule 13D/A) face board veto on >20% buyers. Any new pill must trigger at 20%+, vs 15% before. Value: about $200.5M at the $6.115 close, 4pm ET October 15, 2026. In return the funds are freed from the old pill's 0.001% add-on trigger; sales into a board-approved >50% deal or unopposed tender are exempt. Ends Oct 14, 2030 or when they fall to 20% or less.

Advertisement|Remove ads.